SECURE试验统计分析计划:限制性策略与常规诊疗比较
SECURE试验为多中心、随机、平行臂、非劣效性试验,纳入腹部症状且超声证实胆囊结石或胆泥的患者,比较常规诊疗与基于预设标准阶梯选择的限制性策略。本文在结局数据不可得前提交统计分析计划,主要终点为随访12个月无痛患者比例,采用Izbicki疼痛评分评估。
要点
- 主要终点为12个月随访时无痛患者比例,用Izbicki疼痛评分评估。
- 试验设计为非劣效性,比较限制性阶梯选择策略与常规诊疗。
- 统计分析计划在结局数据不可得前提交,确保分析预设。
核心结论
- SECURE试验将提供证据判断限制性策略是否在患者报告结局相似的同时减少胆囊切除术数量。
研究设计与样本
- 多中心、随机、平行臂、非劣效性试验,纳入腹部症状且超声证实胆囊结石或胆泥的患者。
- 随机分为常规诊疗组或限制性标准化策略组,后者基于预设标准阶梯选择行腹腔镜胆囊切除术。
主要发现
- 有症状胆囊结石患者胆囊切除术后持续疼痛报告率高达40%。
- 本文详细呈现试验统计分析计划,且在研究者获得结局数据前提交。
关键数值与推荐
- 主要终点定义为随访12个月时无痛患者比例,疼痛采用Izbicki疼痛评分评估。
- 次要终点包括胆囊结石或胆囊切除术所致并发症比例、生活质量、症状与治疗关联、工作表现和成本效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cholecystectomy is the preferred treatment for symptomatic cholecystolithiasis. However, persistent pain after cholecystectomy for symptomatic cholecystolithiasis is reported in up to 40% of patients. The aim of the SECURE trial is to compare the effectiveness of usual care with a restrictive strategy using a standardized work-up with stepwise selection for cholecystectomy in patients with gallstones and abdominal complaints. The SECURE trial is designed as a multicenter, randomized, parallel-arm, non-inferiority trial in patients with abdominal symptoms and ultrasound-proven gallstones or sludge. Randomization was performed to either usual care (standard practice, according to the physician's knowledge and experience, and physician's and patient's preference) or a restrictive standardized strategy: treated with interval evaluation and stepwise selection for laparoscopic cholecystectomy based on fulfilment of pre-specified criteria. This article presents in detail the statistical analysis plan (SAP) of this trial and was submitted before outcomes were available to the investigators. RESULTS: The primary end point of this trial is defined as the proportion of patients being pain-free at 12 months' follow-up. Pain will be assessed with the Izbicki Pain Score. Secondary endpoints will be the proportion of patients with complications due to gallstones or cholecystectomy, quality of life, the association between the patients' symptoms and treatment, work performance, and cost-effectiveness. DISCUSSION: The data from the SECURE trial will provide evidence whether or not a restrictive strategy in patients with symptomatic cholecystolithiasis is associated with similar patient reported outcomes and a reduction in the number of cholecystectomies compared to usual care. The data from this trial will be analyzed according to this pre-specified SAP. TRIAL REGISTRATION: The Netherlands National Trial Register NTR4022 . Registered on 5 June 2013.
引用
- Wennmacker SZ, van Dijk AH, Drenth JPH, et al. Statistical analysis plan of a randomized controlled trial to compare a restrictive strategy to usual care for the effectiveness of cholecystectomy (SECURE trial). Trials. 2018. PMID: 30390706. doi:10.1186/s13063-018-2989-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。